
Usman Nazir MD
Critical Care Medicine, Sleep Medicine
Instructor, Internal Medicine, University Kansas School of Medicine
Join to view full profile
6040 Rainbow BlvdStop 1020Kansas City, KS 66160
Phone+1 913-588-6005
Fax+1 913-588-3877
Dr. Nazir is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Usman Nazir is a pulmonologist based in Kansas City, KS, with subspecialties in critical care and sleep medicine. Dr. Nazir completed a residency in internal medicine in 2011 and a fellowship in pulmonary disease and critical care medicine in 2015, both at the University of Kansas School of Medicine. Graduating from Jagiellonian University Medical College in 2007, Dr. Nazir is experienced in managing advanced cardiac life support, acute respiratory distress syndrome, ventilator management, narcolepsy, and restless legs syndrome. A notable publication is a trial on losartan for COVID-19, cited 14 times
Education & Training
University of Kansas School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2015
University of Kansas School of MedicineResidency, Internal Medicine, 2011
Jagiellonian University Medical CollegeClass of 2007
Certifications & Licensure
KS State Medical License 2011 - 2027
MO State Medical License 2022 - 2027
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- 14 citationsAn Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19Charles D. Bengtson, Robert N. Montgomery, Usman Nazir, Lewis Satterwhite, Michael D. Kim
Frontiers in Medicine. 2021-02-17
Press Mentions
Inspire Medical Systems, Inc. Announces the 5,000th Patient to Receive Inspire TherapyApril 16th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









